Paid Clinical Trials in Sherman Oaks, CA
As of August 2026, 29 paid clinical trials are recruiting in Sherman Oaks, California. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Sherman Oaks offers studies at sites including California Neuroscience Research for conditions such as Major Depressive Disorder, Alzheimer Disease, Alzheimers Disease, Schizophrenia. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Sherman Oaks
Trials by drug in Sherman Oaks
Filter results
Newly added in Sherman Oaks
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
28 clinical trials
A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
A Study to Investigate Efficacy, Safety and Tolerability of Barzolvolimab Versus Placebo in Adults With Cold Induced Urticaria and Symptomatic Dermographism Inadequately Controlled by H1-antihistamines (EMBARQ - ColdU and SD)
A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder
Shield Post-Approval Study Protocol
Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder (ASD) in Pediatric Patients
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
Study of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety Disorder
Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
A Biospecimen Collection Study to Identify the Targets of Disease-Reactive T Cells in Patients With Autoimmune Disease
A Phase 2, Baseline-Controlled Study Evaluating the Safety and Efficacy of PTX-022 (Sirolimus) Topical Gel 3.9% in the Treatment of Angiokeratomas (LOTU)
International Multicentric Observational Study to Characterize Subpopulations of Patients With Autism Spectrum Disorder
A Clinical Trial to Assess the Efficacy, Safety, and Tolerability of a Repeat Dose of Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists
A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M)
Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine and a Marketed Measles, Mumps and Rubella Vaccine When Administered as Intramuscular Injection to Healthy Children 12 to 15 Months of Age
Top Research Study Locations in Sherman Oaks
Researchers run research studies in Sherman Oaks, CA at 20 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| California Neuroscience Research | Autism Spectrum Disorder, Generalized Anxiety Disorder, Irritability Associated With Autism Spectrum Disorder | 4 |
| Amicis Research Center | Chronic Inducible Urticaria, Cold Urticaria, Cold-Induced Urticaria | 2 |
| CenExel Sherman Oaks CA (California Neuroscience Research) | Acute Migraine, Migraine | 2 |
| Cenexel California Neuroscience Research, LLC | Alzheimers Disease | 2 |
| GSK Investigational Site | Chickenpox, Irritable Bowel Syndrome | 2 |
| Integrated Clinical Research | Atherosclerotic Cardiovascular Disease (ASCVD), Elevated Lp(a), HPV | 2 |
| Accellacare - Sherman Oaks | Agitation, Alzheimer Disease | 1 |
| Advanced Dermatology and Skin Cancer Institute - Beverly Hills | Plaque Psoriasis | 1 |
| CenExel CNR | Major Depressive Disorder | 1 |
| CenExel Sherman Oaks | Alzheimer Disease, Alzheimer Disease Due to P. Gingivalis | 1 |
| Cenexel Cnr - Sherman Oaks | Major Depressive Disorder | 1 |
| Cura Clinical Research | Ankylosing Spondylitis, Autoimmune Diseases, Birdshot Chorioretinitis | 1 |
| FIN-10423, Sherman Oaks, CA | Heart Failure | 1 |
| Investigative | Hidradenitis Suppurativa (HS) | 1 |
| Neurocrine Clinical Site | Schizophrenia | 1 |
| Radiance Surgery Center | Lumbar Spinal Stenosis | 1 |
| Schuster Medical Research Institute | Bipolar I Disorder, Bipolar II Disorder | 1 |
| Unified Health | Angiokeratomas | 1 |
| Unison Clinical Trials | Plaque Psoriasis | 1 |
| Vistagen Clinical Site | Social Anxiety Disorder | 1 |
Active & Upcoming Studies in Sherman Oaks (2026)
Recruiting trials in Sherman Oaks grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Mental health & behavior (5 active studies)
- A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia · Phase 2 · MapLight Therapeutics
- A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder · Phase 2 · AbbVie
Neurology & pain (5 active studies)
- A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine · Phase 3 · Kallyope Inc.
- A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine · Phase 3 · Kallyope Inc.
Cancer & tumors (1 active study)
- Shield Post-Approval Study Protocol · Guardant Health, Inc.
Cardiovascular (1 active study)
Common conditions studied in Sherman Oaks
- Major Depressive Disorder (3 active studies)
- Alzheimer Disease (2 active studies)
- Alzheimers Disease (2 active studies)
- Schizophrenia (2 active studies)
- Acute Migraine (1 active study)
- Agitation (1 active study)
Leading research sponsors in Sherman Oaks
- AbbVie
- GlaxoSmithKline
- Hoffmann-La Roche
- Intra-Cellular Therapies, Inc.
- Kallyope Inc.
Frequently asked questions
How many paid clinical trials are currently recruiting in Sherman Oaks?
There are approximately 29 recruiting clinical trials in Sherman Oaks, California listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Sherman Oaks pay participants?
Most recruiting trials in Sherman Oaks compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Sherman Oaks?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Sherman Oaks?
The most common conditions under active study in Sherman Oaks include Major Depressive Disorder (3), Alzheimer Disease (2), Alzheimers Disease (2), Schizophrenia (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Sherman Oaks?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Sherman Oaks on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Sherman Oaks?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Sherman Oaks?
Recruiting research sites in Sherman Oaks include California Neuroscience Research, Amicis Research Center, CenExel Sherman Oaks CA (California Neuroscience Research), among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Sherman Oaks right now?
The largest active categories in Sherman Oaks are Mental health & behavior (5), Neurology & pain (5), Cancer & tumors (1). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.